Q: Your opinion on a 3% holding in HHL for income would be appreciated.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Stock is down after hours. Is it that serious? Is it time to sell?
Q: comments,please,on recent drop in share value.
Q: Thinking of purchasing for a long term hold. Would this be a wise move or is there another company you would prefer? Thanks as always.
Q: Is there a future in this company? Your view would be appreciated.
- Pfizer Inc. (PFE)
- Zoetis Inc. Class A (ZTS)
- iShares Global Healthcare Index ETF (CAD-Hedged) (XHC)
- iShares U.S. Medical Devices ETF (IHI)
Q: Good morning 5i, I am still plodding along with asset allocator. I have only Weed left in healthcare having sold GUD, and COV. I need 9% so another 7% after WEED. Happy to buy in $US or $Cdn and looking at XHC, IHI, PFE, ZTS. I appreciate your input. Regards, Ted
Q: Good morning team,
Re: Gud's NCIB:
“Be mindful that the largest beneficiary of the share repurchase program is Jonathan Goodman. Even if he does not participate, the reduction of shares at a substantial discount to last $10 per share capital raise only serves to increase his percentage control of the company. Like his conflicting interests with his family business (Pharmascience), either way he wins and shareholders lose.
“Rather than engage in financial engineering that principally benefits the CEO, why didn’t the Board consider a partial tender offer for shares at $10? Just give shareholders their money back at the price paid? It’s a fair question. But one that we fully expect the company to ignore.
https://ca.finance.yahoo.com/news/medison-biotech-jonathan-goodman-takes-124100485.html
Comments please,
Thank you!
Re: Gud's NCIB:
“Be mindful that the largest beneficiary of the share repurchase program is Jonathan Goodman. Even if he does not participate, the reduction of shares at a substantial discount to last $10 per share capital raise only serves to increase his percentage control of the company. Like his conflicting interests with his family business (Pharmascience), either way he wins and shareholders lose.
“Rather than engage in financial engineering that principally benefits the CEO, why didn’t the Board consider a partial tender offer for shares at $10? Just give shareholders their money back at the price paid? It’s a fair question. But one that we fully expect the company to ignore.
https://ca.finance.yahoo.com/news/medison-biotech-jonathan-goodman-takes-124100485.html
Comments please,
Thank you!
Q: In doing my research I see 4 strong buys on analysts following the company. It seems to have a target of $35.
What do you think of it? Would you reccomend it as part of a growth portfolio?
Please advise.
Sheldon
What do you think of it? Would you reccomend it as part of a growth portfolio?
Please advise.
Sheldon
Q: Do you see any reason for the big drop today?
Q: Thoughts?
http://www.globenewswire.com/news-release/2019/07/08/1879781/0/en/Knight-Announces-Normal-Course-Issuer-Bid.html
http://www.globenewswire.com/news-release/2019/07/08/1879781/0/en/Knight-Announces-Normal-Course-Issuer-Bid.html
Q: Hi 5i,
Can I get your thoughts on Personalis, Inc.? It has pulled back since the IPO. What do you think of the risk/reward ratio? Would it compare to Guardant?
TIA!
Can I get your thoughts on Personalis, Inc.? It has pulled back since the IPO. What do you think of the risk/reward ratio? Would it compare to Guardant?
TIA!
Q: Does the legal action started have any possibility? Most of these issues end up dying a slow death. Shareholders have been deceived but whether there is sufficient fact here is questionable as is the usual response of the TSX and authorities to simply allow managements actions that are clearly against minority shareholders wishes. It would be nice to see some teeth in investor law.
Q: Hi 5i team,
Thank you for your answer on Eidos Therapeutic on 21st, June. I own this stock and has gone up 30% + thanks to your positive comment ( at least the ceo has bought 28m in shares), I usually hold on to my winner and let it runs, but I do not understand why it gone up so fast within a short period of time with no news.
As stated in your answer, the company has no revenue and is still losing money. Do you see further upside for this stock ? Should I continue to hold ?
Thank you for your excellent service and helpful advice as always.
Thank you for your answer on Eidos Therapeutic on 21st, June. I own this stock and has gone up 30% + thanks to your positive comment ( at least the ceo has bought 28m in shares), I usually hold on to my winner and let it runs, but I do not understand why it gone up so fast within a short period of time with no news.
As stated in your answer, the company has no revenue and is still losing money. Do you see further upside for this stock ? Should I continue to hold ?
Thank you for your excellent service and helpful advice as always.
Q: i love high risk, high reward stocks, you keep bringing up guardant health in this category. why do you like it so much. dave
Q: WELL stock continues to do...well...very well. Today it is up over 15% but I couldn't find any news to account for the spike. Do you have any idea?
Q: Thinking of investing in US drug company GIL. The whole sector seems hammered which I think may be a result of the US presidential race...I'm more of a " Tell me what they're up to " kind of investor as opposed to earnings per share and how many of their last quarters they've beat......Would like to know the good and bad about GIL ..... And one important factor... Are they in any way effected by the various state sponsored opioid lawsuits . I don't want any where near any of those companies. It looks like they may be in a lot of trouble. .... Of any country's drug companies would it be 5I's choice ? If not what would be 5I's current favorite ? Thank you for your sound advice......
Q: Hello 5i: I have sold my JNJ and looking for another healthcare and would like your suggestions. I already hold PFE Thank you Barb
Q: Did your team listen to the Corp
Webinar?? If , what did you think??
Webinar?? If , what did you think??
Q: Your opinion on this company , please.
Q: Hello,
What do you think about Nova Leap Healthcare? Company is growing by acquisitions and insiders hold over 30% in the company. Company increased revenues from $1M to $12M from 2017 to 2018.
What do you think about Nova Leap Healthcare? Company is growing by acquisitions and insiders hold over 30% in the company. Company increased revenues from $1M to $12M from 2017 to 2018.